Sentences with phrase «number of technology candidates»

That's a question I recently asked an expert — Jeff Lipschultz, owner of A-List Solutions, a recruiting firm in the Dallas area that places a large number of technology candidates all over the country.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«At the end of the day, a candidate has a number in mind as to what he or she thinks is appropriate,» says Eddie R. Koller III, executive recruiter and partner at Koller Search Partners, a technology and media recruiting firm.

Determining the number of people who stand to benefit from the technology is more difficult because different people suffer from different degrees of blindness, but it's fair to say that candidates for Pezaris's implants are more likely to be those who are totally blind, whether from birth or due to a traumatic brain injury.

These shortcomings, as well as the same demands that drive most technological innovation — to make it smaller, faster, cheaper, less prone to failure — have produced a number of candidate data - storage technologies in recent years, all of which offer some combination of advantages over the devices in wide use today.

In this role, we serve as the incubator of a number of science and technology startups, including our spinoff, Novo Biosciences, whose goal is to commercialize the regenerative medicine drug candidates we have discovered.

Organisations such as the Cultural Learning Alliance, the National Society for Educators in Art and Design and the Design and Technology Association have separately gathered evidence that clearly shows a fall in the number of candidates taking creative subjects at GCSE and A Level.

With over 15 years experience, we help schools and colleges recruit better, smarter, faster, by providing a number of recruitment solutions including best value advertising, education recruitment experts, innovative technology and operate as a strategic recruitment partner to deliver outstanding candidate results.

Our matching technology puts your job listing in front of active, qualified candidates looking for new job opportunities — on our site, through our vast partner network and via email — to increase the number of quality applications you receive.

«At the end of the day, a candidate has a number in mind as to what they think they're worth,» says Eddie R. Koller III, executive recruiter and partner at Koller Search Partners, a technology and media recruiting firm.

I see a number of candidates every day at our assessment centres and those that stand out for me demonstrate enthusiasm, motivation, a keen interest in technology, an analytical mind and logical thinking.

Perhaps you were chosen out of a number of candidates for a particular role; perhaps you were quickly promoted within your company; or perhaps you took courses in leadership or in a technology important to your company.